Back

Serum Total Immunoglobulin-E Levels and Early Loss of eGFR in Individuals at Risk of Mesoamerican Nephropathy: A Nested Case-Control Analysis from a Population Representative Follow-Up Study

Caplin, B.; Agarwal, S.; Day, A.; Al-Rashed, A.; Oomatia, A.; Gonzalez-Quiroz, M.; Pearce, N.

2026-03-02 nephrology
10.64898/2026.02.27.25342157 medRxiv
Show abstract

IntroductionThere remains considerable debate as to the cause of the epidemic of Mesoamerican Nephropathy (MeN). We have previously reported early loss of estimated glomerular filtration rate (eGFR) as a surrogate for disease onset in a population-representative cohort study of young-adults at risk of disease from Northwest Nicaragua. Using a nested case-control approach we analysed urine and serum proteins surrounding this timepoint with the aim of gaining insight into the primary disease aetiology. MethodsWe conducted label-free ultra high-performance liquid chromatography mass-spectrometry based proteomics using urine samples collected at the study visit before, and at, first observed eGFR loss amongst cases and compared results to matched controls. We then performed direct protein measurements in a discovery cohort followed by quantification of serum total immunoglobulin E (stIgE) at multiple timepoints in a replication cohort. ResultsProteomic analysis demonstrated no differences in the levels of any single protein between cases and controls (n=25 each), at either timepoint, after correction for multiple comparisons. However, functional enrichment analysis demonstrated upregulation of adaptive immune pathways amongst cases. Direct measurements in the discovery cohort using high-sensitivity PCR-based immunoassay (n=21 controls, 19 cases) demonstrated higher stIgE in cases at the study visit immediately prior to first observed eGFR loss (mean difference 810kU/L, 95% confidence interval (CI): 162-1457kU/L). In the replication cohort (n=22 cases, 21 controls) an stIgE level >500kU/L measured by electrochemiluminescence in study samples from any timepoint in the 3 years prior to the first observed loss of eGFR was independently associated with case status when compared to samples from controls at matched visits (adjusted Odds Ratio: 8.1, 95% CI: 1.4-47.8). DiscussionA high level of stIgE precedes loss of eGFR in those at risk of MeN. Understanding what leads to this rise is likely to be key to understanding the cause of the MeN epidemic. Lay SummaryMesoamerican nephropathy describes an epidemic-level chronic kidney disease impacting rural working age adults in Central America. Although a number of exposures, including occupational heat exposure, have been proposed the cause of the epidemic, there remains much debate as to the primary aetiology of the disease. In this study we interrogated urine and blood samples from individuals from affected communities at risk of disease both before and after they develop kidney dysfunction. Using two different approaches, analysis of both urine and blood samples provide evidence of upregulation of immunoglobulin-E (IgE) related pathways in the 2-3 years before individuals develop evidence of kidney disease. Infections (particularly those involving parasites) and allergic reactions, but not heat exposure, have been reported to increase IgE levels. Going forwards, understanding the cause of this increase in IgE in individuals at risk of disease is likely to provide insight into the cause of Mesoamerican Nephropathy epidemics.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Kidney International Reports
14 papers in training set
Top 0.1%
22.9%
2
Kidney International
25 papers in training set
Top 0.1%
15.0%
3
Kidney360
22 papers in training set
Top 0.1%
9.3%
4
BMC Nephrology
13 papers in training set
Top 0.1%
6.9%
50% of probability mass above
5
PLOS ONE
4510 papers in training set
Top 26%
6.5%
6
The FASEB Journal
175 papers in training set
Top 0.1%
6.4%
7
Journal of the American Society of Nephrology
52 papers in training set
Top 0.2%
4.9%
8
BMC Medicine
163 papers in training set
Top 2%
2.8%
9
Wellcome Open Research
57 papers in training set
Top 0.4%
2.8%
10
Pathogens
53 papers in training set
Top 0.3%
2.1%
11
JCI Insight
241 papers in training set
Top 2%
2.1%
12
Scientific Reports
3102 papers in training set
Top 53%
1.9%
13
iScience
1063 papers in training set
Top 19%
1.4%
14
Diabetologia
36 papers in training set
Top 0.7%
1.2%
15
PLOS Genetics
756 papers in training set
Top 12%
1.0%
16
Health Science Reports
12 papers in training set
Top 0.2%
0.9%
17
Clinical Proteomics
10 papers in training set
Top 0.1%
0.9%
18
BMJ Open Diabetes Research & Care
15 papers in training set
Top 0.9%
0.8%
19
Cardiovascular Research
33 papers in training set
Top 0.9%
0.8%
20
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 2%
0.8%
21
JAMA Network Open
127 papers in training set
Top 4%
0.8%
22
eLife
5422 papers in training set
Top 59%
0.7%
23
PLOS Medicine
98 papers in training set
Top 5%
0.7%
24
American Journal of Physiology-Renal Physiology
25 papers in training set
Top 0.3%
0.7%